| Dr Daniel Diperna, PSYD | |
|
4205 Hillsboro Pike Ste 301, Nashville, TN 37215-3339 | |
| (615) 714-1151 | |
| Not Available |
| Full Name | Dr Daniel Diperna |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 4205 Hillsboro Pike Ste 301, Nashville, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003422874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 3713 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Diperna, PSYD 4205 Hillsboro Pike Ste 301, Nashville, TN 37215-3339 Ph: (615) 714-1151 | Dr Daniel Diperna, PSYD 4205 Hillsboro Pike Ste 301, Nashville, TN 37215-3339 Ph: (615) 714-1151 |
News Archive
Forest Laboratories, Inc. and Almirall, S.A. today announced top-line results from ACCORD COPD II, a 12-week Phase III study comparing the efficacy and safety of inhaled aclidinium bromide, an investigative bronchodilator, to placebo in 544 patients with moderate to severe COPD.
Shana Dorsey first caught sight of the purplish wound on her father's lower back as he lay in a suburban Chicago hospital bed a few weeks before his death.
The inability to adequately respond to infection can cause a whole-body state of inflammation known as sepsis. This can eventually lead to systemic inflammatory response syndrome (SIRS), and even death.
Non-alcoholic fatty liver disease (NAFLD) is a common affliction, affecting almost 30 percent of Americans, with a significant number suffering from its most severe form, called non-alcoholic steatohepatitis or NASH, which can lead to cirrhosis and liver cancer. In recent years, NASH has become the leading cause of liver transplantation.
The Gamida Cell-Teva Joint Venture (JV) announced today that the Paediatric Committee (PDCO) of the EMA has granted product specific waivers for StemEx for all subsets of the paediatric population (birth to 17 years of age) in all conditions. The PDCO emphasized that the granting of the waivers should not prevent the JV from considering developing StemEx for children with conditions where there is a need. StemEx is being developed by a joint venture equally owned and operated by Gamida Cell and Teva Pharmaceuticals ( TEVA).
› Verified 9 days ago
Dr. Heather Kreth, PSY.D Psychologist Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 | |
Dr. Elizabeth Leigh Vanhorn, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1720 W End Ave Ste 240, Nashville, TN 37203 Phone: 615-320-1155 | |
Dr. Charles Russell Williams, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 201 23rd Ave N, Nashville, TN 37203 Phone: 615-348-7908 | |
William Michael Hart, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1101 Black Cherry Ct, Nashville, TN 37215 Phone: 415-509-1117 | |
Tori Ella Foster, PHD, BCBA, PLMHP Psychologist Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Dr. Andre Wielemaker, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4235 Hillsboro Pike Ste 300, Nashville, TN 37215 Phone: 615-674-6933 |